Piramal starts Phase-II clinical trials of diabetes drug

21 Sep 2010 Evaluate

Piramal Life Sciences has started Phase-II clinical trials of a molecule ‘P1736-05, aimed at treating diabetes, in Europe and India. P1736-05 is likely to provide a safe and effective therapeutic option to type-2 diabetic patients.

While the company has been granted an approval by the Indian regulatory authorities, in Europe various EU regulatory authorities like CCMO of Netherlands and NIP of Hungary have granted an approval for conducting the trials.

crackcrack

Piramal Phyt-Amalga Share Price

22.55 0.00 (0.00%)
10-Dec-2019 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1789.40
Dr. Reddys Lab 1175.00
Cipla 1528.90
Lupin 2042.50
Zydus Lifesciences 866.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...